Adam H. Schechter, EVP & Pres-Global Human Health at Merck & Co. Inc. (MRK), sold 22,000 shares at $59.70 ($1.3M) on 2014-08-25, disclosed to the SEC on 2014-08-25.
Scheduled sale ($1.3M) by EVP & Pres-Global Human Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| LH | SELL | 2026-03-05 | $2.4M | — | Filing → |
| LH | SELL | 2026-02-13 | $1.5M | — | Filing → |
| LH | SELL | 2025-11-13 | $3.0M | — | Filing → |